113 related articles for article (PubMed ID: 25942346)
1. Significant impact of IL-6 -174G/C but inverse relation with -634 C/G polymorphism in patients with non-small cell lung cancer in Kashmiri population.
Bhat IA; Qasim I; Masoodi KZ; Paul SA; Bhat BA; Rasool R; Aziz SA; Shah ZA
Immunol Invest; 2015; 44(4):349-60. PubMed ID: 25942346
[TBL] [Abstract][Full Text] [Related]
2. Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: A case control study.
Rafrafi A; Chahed B; Kaabachi S; Kaabachi W; Maalmi H; Hamzaoui K; Sassi FH
Hum Immunol; 2013 Oct; 74(10):1368-74. PubMed ID: 23831257
[TBL] [Abstract][Full Text] [Related]
3. Correlation analysis between an IL-6 genetic polymorphism and non-small cell lung cancer prognosis.
Zhao K; Xu J; Tian H
Genet Mol Res; 2016 Mar; 15(1):15017021. PubMed ID: 26985948
[TBL] [Abstract][Full Text] [Related]
4. Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of IL-4.
Gomes M; Coelho A; Araújo A; Teixeira AL; Catarino R; Medeiros R
Gene; 2012 Aug; 504(1):111-5. PubMed ID: 22583827
[TBL] [Abstract][Full Text] [Related]
5. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
7. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
Lou Y; Fang CQ; Li JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
[TBL] [Abstract][Full Text] [Related]
8. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
[TBL] [Abstract][Full Text] [Related]
9. Variant of BCL3 gene is strongly associated with five-year survival of non-small-cell lung cancer patients.
Dimitrakopoulos FI; Antonacopoulou AG; Kottorou A; Marousi S; Koukourikou I; Kalofonou M; Panagopoulos N; Scopa C; Dougenis D; Papadaki H; Papavassiliou AG; Kalofonos HP
Lung Cancer; 2015 Sep; 89(3):311-9. PubMed ID: 26122346
[TBL] [Abstract][Full Text] [Related]
10. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
12. IL-6 polymorphism in non-small cell lung cancer: a prognostic value?
Gomes M; Coelho A; Araújo A; Azevedo A; Teixeira AL; Catarino R; Medeiros R
Tumour Biol; 2015 May; 36(5):3679-84. PubMed ID: 25566963
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase gene in lung cancer.
Takehara A; Kawakami K; Ohta N; Oyama K; Ota Y; Oda M; Watanabe G
Anticancer Res; 2005; 25(6C):4455-61. PubMed ID: 16334126
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17A and -17F genes polymorphisms in lung cancer.
Kaabachi W; ben Amor A; Kaabachi S; Rafrafi A; Tizaoui K; Hamzaoui K
Cytokine; 2014 Mar; 66(1):23-9. PubMed ID: 24548421
[TBL] [Abstract][Full Text] [Related]
16. CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer.
Pan JH; Han JX; Wu JM; Sheng LJ; Huang HN
Acta Oncol; 2007; 46(3):361-6. PubMed ID: 17450472
[TBL] [Abstract][Full Text] [Related]
17. Role of interleukin-6 gene polymorphisms in the development of prostate cancer.
Chen CH; Gong M; Yi QT; Guo JH
Genet Mol Res; 2015 Oct; 14(4):13370-4. PubMed ID: 26535651
[TBL] [Abstract][Full Text] [Related]
18. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
19. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
[TBL] [Abstract][Full Text] [Related]
20. [Polymorphic variants of genes encoding interleukin-6 and fibrinogen, the risk of ischemic stroke and fibrinogen levels].
Titov BV; Barsova RM; Martynov MIu; Nikonova AA; Favorov AV; Gusev EI; Favorova OO
Mol Biol (Mosk); 2012; 46(1):93-102. PubMed ID: 22642105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
